#EXP00162

General

Accession EXP00162
Activity Preformed biofilm
Date 2013-11-26
Administration In solution
Model in vitro
Organism Stenotrophomonas maltophilia
Status Validated
Notes Sm143 clinical isolate

Peptide

BMAP-28

GGLRSLGRKILRAWKKYGPIIVPIIRI

Experimental activity

Method Concentration Notes
Total countable CFUs 2.603 uM No notes
Crystal violet assay 26.034 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814